Patents Assigned to Trinity Pharma Group
  • Publication number: 20160263082
    Abstract: The present invention relates to a method for treating symptoms from a nicotine withdrawal comprising administering to a patient an effective amount of a transdermal compound. In one embodiment the compound includes the following active ingredients: Sertraline, Imipramine, Topiramate, and Bupropion, while in another embodiment the active ingredients are: Fluoxetine, Nortriptyline, Topiramate, and Bupropion.
    Type: Application
    Filed: September 14, 2015
    Publication date: September 15, 2016
    Applicant: TRINITY PHARMA GROUP
    Inventors: Kruitka Patel, Devan Patel
  • Publication number: 20160263018
    Abstract: The present invention relates to a method for treating symptoms from a nicotine withdrawal comprising administering to a patient an effective amount of a transdermal compound. In one embodiment the compound includes the following active ingredients: Sertraline, Imipramine, Topiramate, and Bupropion, while in another embodiment the active ingredients are: Fluoxetine, Nortriptyline, Topiramate, and Bupropion.
    Type: Application
    Filed: March 12, 2015
    Publication date: September 15, 2016
    Applicant: Trinity Pharma Group
    Inventors: Kruitka Patel, Devan Patel
  • Publication number: 20150320816
    Abstract: The present invention relates to a wound healing and scar reduction composition that is a unique product with key ingredients carefully selected to optimize scar reduction. The composition when used can help reduce the appearance of old and new scars. It is an ideal choice for use on all types of scar tissue including, new scars, old scars, surgical, keloids, hypertrophic, stretch marks and any skin condition that would benefit from barrier protection.
    Type: Application
    Filed: May 6, 2015
    Publication date: November 12, 2015
    Applicant: Trinity Pharma Group
    Inventors: Devan Patel, Krutika Patel